A Cell-based Computational Modeling Approach for Developing Site-Directed Molecular Probes

Modeling the local absorption and retention patterns of membrane-permeant small molecules in a cellular context could facilitate development of site-directed chemical agents for bioimaging or therapeutic applications. Here, we present an integrative approach to this problem, combining in silico computational models, in vitro cell based assays and in vivo biodistribution studies. To target small molecule probes to the epithelial cells of the upper airways, a multiscale computational model of the lung was first used as a screening tool, in silico. Following virtual screening, cell monolayers differentiated on microfabricated pore arrays and multilayer cultures of primary human bronchial epithelial cells differentiated in an air-liquid interface were used to test the local absorption and intracellular retention patterns of selected probes, in vitro. Lastly, experiments involving visualization of bioimaging probe distribution in the lungs after local and systemic administration were used to test the relevance of computational models and cell-based assays, in vivo. The results of in vivo experiments were consistent with the results of in silico simulations, indicating that mitochondrial accumulation of membrane permeant, hydrophilic cations can be used to maximize local exposure and retention, specifically in the upper airways after intratracheal administration.

[1]  Gus R Rosania,et al.  Effect of Phospholipidosis on the Cellular Pharmacokinetics of Chloroquine , 2011, Journal of Pharmacology and Experimental Therapeutics.

[2]  Lee Campbell,et al.  Expression and Transport Functionality of FcRn within Rat Alveolar Epithelium: A Study in Primary Cell Culture and in the Isolated Perfused Lung , 2005, Pharmaceutical Research.

[3]  Simon Cawthorne,et al.  Particle engineering techniques for inhaled biopharmaceuticals. , 2006, Advanced drug delivery reviews.

[4]  Panos Macheras,et al.  Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches , 2005 .

[5]  R. Horobin,et al.  A predictive model for the selective accumulation of chemicals in tumor cells , 2005, European Biophysics Journal.

[6]  Kerby Shedden,et al.  A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration. , 2006, Molecular pharmaceutics.

[7]  Hans Lennernäs,et al.  Drug Absorption from the Isolated Perfused Rat Lung–Correlations with Drug Physicochemical Properties and Epithelial Permeability , 2003, Journal of drug targeting.

[8]  C. Lehr,et al.  Cell culture models of the respiratory tract relevant to pulmonary drug delivery. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[9]  M. Burton,et al.  Applied pharmacokinetics & pharmacodynamics : principles of therapeutic drug monitoring , 2006 .

[10]  H C Yeh,et al.  Anatomic Models of the tracheobronchial and pulmonary regions of the rat , 1979, The Anatomical record.

[11]  Patrick Poulin,et al.  Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. , 2002, Journal of pharmaceutical sciences.

[12]  R. Niven,et al.  Delivery of biotherapeutics by inhalation aerosol. , 1995, Critical reviews in therapeutic drug carrier systems.

[13]  Huaning Zhu,et al.  Cells on pores: a simulation-driven analysis of transcellular small molecule transport. , 2010, Molecular pharmaceutics.

[14]  Min-Ki Lee,et al.  Air-Liquid Interface Culture of Serially Passaged Human Nasal Epithelial Cell Monolayer for In Vitro Drug Transport Studies , 2005, Drug delivery.

[15]  M D Blaufox,et al.  Blood volume in the rat. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  G A Prince,et al.  Cryostat microtomy of lung tissue in an expanded state. , 1975, Stain technology.

[17]  O. Usmani,et al.  Regional Lung Deposition and Bronchodilator Response as a Function of β2-Agonist Particle Size , 2005 .

[18]  Jing-yu Yu,et al.  Cell-Based Multiscale Computational Modeling of Small Molecule Absorption and Retention in the Lungs , 2010, Pharmaceutical Research.

[19]  D M Hyde,et al.  Airway generation‐specific differences in the spatial distribution of immune cells and cytokines in allergen‐challenged rhesus monkeys , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  M. H. Ross,et al.  Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. Eighth Edition, 2018 Authors: Wojciech Pawlina; Michael H. Ross , 2019, Morphologia.

[21]  Hartmut Derendorf,et al.  Pharmacokinetic/Pharmacodynamic Modeling in Drug Research and Development , 2000, Journal of clinical pharmacology.

[22]  Burkhard Lachmann,et al.  Lung clearance of intratracheally instilled 99mTc‐tobramycin using pulmonary surfactant as vehicle , 1999, British journal of pharmacology.

[23]  Xinyuan Zhang,et al.  Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines , 2008, J. Comput. Aided Mol. Des..

[24]  R. A. Parent,et al.  Comparative biology of the normal lung , 1992 .

[25]  Min-Ki Lee,et al.  Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies. , 2007, Journal of pharmaceutical sciences.

[26]  Hedayatollah Zaghi,et al.  Respiratory Medicine , 1987, The Yale Journal of Biology and Medicine.

[27]  Hans Lennernäs,et al.  Regional differences in bioavailability of an opioid tetrapeptide in vivo in rats after administration to the respiratory tract , 2002, Peptides.

[28]  M. King Experimental models for studying mucociliary clearance. , 1998, The European respiratory journal.

[29]  Kathleen A Stringer,et al.  Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[30]  C. Witham,et al.  Dry powder inhalation as a potential delivery method for vaccines. , 1999, Vaccine.

[31]  Ann Tronde Pulmonary Drug Absorption : In vitro and in vivo investigations of drug absorption across the lung barrier and its relation to drug physicochemical properties , 2002 .

[32]  Ben Forbes,et al.  In‐vitro respiratory drug absorption models possess nominal functional P‐glycoprotein activity , 2009, The Journal of pharmacy and pharmacology.

[33]  E. Weibel,et al.  Principles and methods for the morphometric study of the lung and other organs. , 1963, Laboratory investigation; a journal of technical methods and pathology.

[34]  Min-Ki Lee,et al.  Serially Passaged Human Nasal Epithelial Cell Monolayer for in Vitro Drug Transport Studies , 2003, Pharmaceutical Research.

[35]  Peter R. Byron,et al.  Inhaling medicines: delivering drugs to the body through the lungs , 2007, Nature Reviews Drug Discovery.

[36]  Mark Gumbleton,et al.  Challenges and innovations in effective pulmonary systemic and macromolecular drug delivery. , 2006, Advanced drug delivery reviews.

[37]  M. Rowland,et al.  Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. , 2005, Journal of pharmaceutical sciences.

[38]  Magnus Svartengren,et al.  Particle Clearance in Human Bronchial Airways: Comparison of Stochastic Model Predictions with Experimental Data , 2002 .

[39]  L. Abdullah,et al.  Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. , 1996, American journal of respiratory cell and molecular biology.